SNDX

Latest SEC Filings & News for SNDX

1 most recent filing and news item mentioning SNDX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/SNDX/news?limit=20"

Pull SNDX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

Syndax Pharmaceuticals offers convertible senior notes due 2031

Syndax Pharmaceuticals is issuing convertible senior notes due 2031 to accredited and institutional investors without SEC registration. The offering allows conversion into cash, common stock, or a combination thereof at the company's election.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.